|
PUM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.631400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.887200E-01 |
| Normal-vs-Stage2 |
3.582400E-01 |
| Normal-vs-Stage3 |
3.409000E-01 |
| Normal-vs-Stage4 |
2.273800E-01 |
| Stage1-vs-Stage2 |
8.284200E-01 |
| Stage1-vs-Stage3 |
7.983000E-01 |
| Stage1-vs-Stage4 |
6.715200E-01 |
| Stage2-vs-Stage3 |
9.942200E-01 |
| Stage2-vs-Stage4 |
9.123000E-01 |
| Stage3-vs-Stage4 |
9.244400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.142400E-01 |
| Normal-vs-AfricanAmerican |
3.854000E-02 |
| Normal-vs-Asian |
8.839700E-02 |
| Caucasian-vs-AfricanAmerican |
4.931800E-02 |
| Caucasian-vs-Asian |
4.552600E-01 |
| AfricanAmerican-vs-Asian |
7.098000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.439650E-01 |
| Normal-vs-Female |
5.854400E-01 |
| Male-vs-Female |
6.613600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.357000E-01 |
| Normal-vs-Extreme_Weight |
3.883700E-02 |
| Normal-vs-Obese |
9.878800E-01 |
| Normal-vs-Extreme_Obese |
5.740800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.278600E-01 |
| Normal_Weight-vs-Obese |
3.479000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.032400E-01 |
| Extreme_Weight-vs-Obese |
1.053450E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.857000E-01 |
| Obese-vs-Extreme_Obese |
6.684400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.736000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.231800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.412300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.043500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.891000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.573400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.925440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.113900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.118450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.742600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.762200E-01 |
| Normal-VS-Type2 PRCC |
6.219800E-02 |
| Normal-VS-KIRP CIMP |
6.852400E-01 |
| Normal-VS-Unclassified PRCC |
8.125400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.026100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.805400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.593400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.422800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.268000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.044600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.427980E-02 |
| Normal-vs-N1 |
8.107200E-01 |
| Normal-vs-N2 |
4.073000E-01 |
| N0-vs-N1 |
1.115360E-01 |
| N0-vs-N2 |
7.573800E-01 |
| N1-vs-N2 |
6.233800E-01 |
|
|
